The recent discovery of several potentially pathogenic autoantibodies has helped identify patients with clinically distinctive central nervous system diseases that appear to benefit from immunotherapy. The associated autoantibodies are directed against the extracellular domains of cell-surface-expressed neuronal or glial proteins such as LGI1, N-methyl-D-aspartate receptor, and aquaporin-4. The original descriptions of the associated clinical syndromes were phenotypically well circumscribed. ...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Cell-surface central nervous system autoantibodies: clinical relevance and emerging paradigms.
Views and Downloads
If you are the owner of this record, you can report an update to it here: Report update to this record